Review



b s aureus atcc 43300  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    ATCC b s aureus atcc 43300
    A Evolution of resistant mutants of SMJ-2 (blue) and ciprofloxacin (brown) in cation-adjusted broth on S. aureus ATCC 29213, B S. aureus ATCC 43300, and ( C ) B. subtilis MTCC 121. Cells were passaged every 24 h. D , E Time-kill kinetic assay of SMJ-2 and SMJ-4 on S. aureus ATCC-MRSA-43300 in logarithmic and stationary phase respectively, the concentration of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin at 10 × MIC. MIC of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin were 2, 4, 1, 2, and 64 µg mL −1 respectively; (L.O.D. = Limit of Detection), F Photographic representation of SMJ-2, SMJ-4, vancomycin and linezolid treatment on S. aureus ATCC-MRSA-43300 in logarithmic phase, G Oxacillin treatment to S. aureus ATCC-29213 form persister cells, H Persister killing assay in the presence of SMJ-2 at 5 × MIC, 10 × MIC, and 20 × MIC and linezolid was used as positive control at 10 × MIC, and 20 × MIC. Experiments ( A – C ) represent two individual repeats ( n = 2 biologically independent experiments), D , E , G , and H represent three individual repeats ( n = 3 biologically independent samples), and the results correspond to average ± standard deviation.
    B S Aureus Atcc 43300, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 7106 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/b s aureus atcc 43300/product/ATCC
    Average 99 stars, based on 7106 article reviews
    b s aureus atcc 43300 - by Bioz Stars, 2026-03
    99/100 stars

    Images

    1) Product Images from "Synthetic indole derivatives as an antibacterial agent inhibiting respiratory metabolism of multidrug-resistant gram-positive bacteria"

    Article Title: Synthetic indole derivatives as an antibacterial agent inhibiting respiratory metabolism of multidrug-resistant gram-positive bacteria

    Journal: Communications Biology

    doi: 10.1038/s42003-024-06996-8

    A Evolution of resistant mutants of SMJ-2 (blue) and ciprofloxacin (brown) in cation-adjusted broth on S. aureus ATCC 29213, B S. aureus ATCC 43300, and ( C ) B. subtilis MTCC 121. Cells were passaged every 24 h. D , E Time-kill kinetic assay of SMJ-2 and SMJ-4 on S. aureus ATCC-MRSA-43300 in logarithmic and stationary phase respectively, the concentration of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin at 10 × MIC. MIC of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin were 2, 4, 1, 2, and 64 µg mL −1 respectively; (L.O.D. = Limit of Detection), F Photographic representation of SMJ-2, SMJ-4, vancomycin and linezolid treatment on S. aureus ATCC-MRSA-43300 in logarithmic phase, G Oxacillin treatment to S. aureus ATCC-29213 form persister cells, H Persister killing assay in the presence of SMJ-2 at 5 × MIC, 10 × MIC, and 20 × MIC and linezolid was used as positive control at 10 × MIC, and 20 × MIC. Experiments ( A – C ) represent two individual repeats ( n = 2 biologically independent experiments), D , E , G , and H represent three individual repeats ( n = 3 biologically independent samples), and the results correspond to average ± standard deviation.
    Figure Legend Snippet: A Evolution of resistant mutants of SMJ-2 (blue) and ciprofloxacin (brown) in cation-adjusted broth on S. aureus ATCC 29213, B S. aureus ATCC 43300, and ( C ) B. subtilis MTCC 121. Cells were passaged every 24 h. D , E Time-kill kinetic assay of SMJ-2 and SMJ-4 on S. aureus ATCC-MRSA-43300 in logarithmic and stationary phase respectively, the concentration of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin at 10 × MIC. MIC of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin were 2, 4, 1, 2, and 64 µg mL −1 respectively; (L.O.D. = Limit of Detection), F Photographic representation of SMJ-2, SMJ-4, vancomycin and linezolid treatment on S. aureus ATCC-MRSA-43300 in logarithmic phase, G Oxacillin treatment to S. aureus ATCC-29213 form persister cells, H Persister killing assay in the presence of SMJ-2 at 5 × MIC, 10 × MIC, and 20 × MIC and linezolid was used as positive control at 10 × MIC, and 20 × MIC. Experiments ( A – C ) represent two individual repeats ( n = 2 biologically independent experiments), D , E , G , and H represent three individual repeats ( n = 3 biologically independent samples), and the results correspond to average ± standard deviation.

    Techniques Used: Kinetic Assay, Concentration Assay, Positive Control, Standard Deviation



    Similar Products

    b s aureus atcc 43300  (ATCC)
    99
    ATCC b s aureus atcc 43300
    A Evolution of resistant mutants of SMJ-2 (blue) and ciprofloxacin (brown) in cation-adjusted broth on S. aureus ATCC 29213, B S. aureus ATCC 43300, and ( C ) B. subtilis MTCC 121. Cells were passaged every 24 h. D , E Time-kill kinetic assay of SMJ-2 and SMJ-4 on S. aureus ATCC-MRSA-43300 in logarithmic and stationary phase respectively, the concentration of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin at 10 × MIC. MIC of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin were 2, 4, 1, 2, and 64 µg mL −1 respectively; (L.O.D. = Limit of Detection), F Photographic representation of SMJ-2, SMJ-4, vancomycin and linezolid treatment on S. aureus ATCC-MRSA-43300 in logarithmic phase, G Oxacillin treatment to S. aureus ATCC-29213 form persister cells, H Persister killing assay in the presence of SMJ-2 at 5 × MIC, 10 × MIC, and 20 × MIC and linezolid was used as positive control at 10 × MIC, and 20 × MIC. Experiments ( A – C ) represent two individual repeats ( n = 2 biologically independent experiments), D , E , G , and H represent three individual repeats ( n = 3 biologically independent samples), and the results correspond to average ± standard deviation.
    B S Aureus Atcc 43300, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/b s aureus atcc 43300/product/ATCC
    Average 99 stars, based on 1 article reviews
    b s aureus atcc 43300 - by Bioz Stars, 2026-03
    99/100 stars
    		  Buy from Supplier
    iliciclin b against s aureus atcc 43300  (ATCC)
    99
    ATCC iliciclin b against s aureus atcc 43300
    A Evolution of resistant mutants of SMJ-2 (blue) and ciprofloxacin (brown) in cation-adjusted broth on S. aureus ATCC 29213, B S. aureus ATCC 43300, and ( C ) B. subtilis MTCC 121. Cells were passaged every 24 h. D , E Time-kill kinetic assay of SMJ-2 and SMJ-4 on S. aureus ATCC-MRSA-43300 in logarithmic and stationary phase respectively, the concentration of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin at 10 × MIC. MIC of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin were 2, 4, 1, 2, and 64 µg mL −1 respectively; (L.O.D. = Limit of Detection), F Photographic representation of SMJ-2, SMJ-4, vancomycin and linezolid treatment on S. aureus ATCC-MRSA-43300 in logarithmic phase, G Oxacillin treatment to S. aureus ATCC-29213 form persister cells, H Persister killing assay in the presence of SMJ-2 at 5 × MIC, 10 × MIC, and 20 × MIC and linezolid was used as positive control at 10 × MIC, and 20 × MIC. Experiments ( A – C ) represent two individual repeats ( n = 2 biologically independent experiments), D , E , G , and H represent three individual repeats ( n = 3 biologically independent samples), and the results correspond to average ± standard deviation.
    Iliciclin B Against S Aureus Atcc 43300, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/iliciclin b against s aureus atcc 43300/product/ATCC
    Average 99 stars, based on 1 article reviews
    iliciclin b against s aureus atcc 43300 - by Bioz Stars, 2026-03
    99/100 stars
    		  Buy from Supplier
    b s atcc 6633 b c atcc 11778 e f atcc 29212 s a atcc 6538 s a atcc 43300 e coli atcc 8739 s typhi  (ATCC)
    99
    ATCC b s atcc 6633 b c atcc 11778 e f atcc 29212 s a atcc 6538 s a atcc 43300 e coli atcc 8739 s typhi
    A Evolution of resistant mutants of SMJ-2 (blue) and ciprofloxacin (brown) in cation-adjusted broth on S. aureus ATCC 29213, B S. aureus ATCC 43300, and ( C ) B. subtilis MTCC 121. Cells were passaged every 24 h. D , E Time-kill kinetic assay of SMJ-2 and SMJ-4 on S. aureus ATCC-MRSA-43300 in logarithmic and stationary phase respectively, the concentration of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin at 10 × MIC. MIC of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin were 2, 4, 1, 2, and 64 µg mL −1 respectively; (L.O.D. = Limit of Detection), F Photographic representation of SMJ-2, SMJ-4, vancomycin and linezolid treatment on S. aureus ATCC-MRSA-43300 in logarithmic phase, G Oxacillin treatment to S. aureus ATCC-29213 form persister cells, H Persister killing assay in the presence of SMJ-2 at 5 × MIC, 10 × MIC, and 20 × MIC and linezolid was used as positive control at 10 × MIC, and 20 × MIC. Experiments ( A – C ) represent two individual repeats ( n = 2 biologically independent experiments), D , E , G , and H represent three individual repeats ( n = 3 biologically independent samples), and the results correspond to average ± standard deviation.
    B S Atcc 6633 B C Atcc 11778 E F Atcc 29212 S A Atcc 6538 S A Atcc 43300 E Coli Atcc 8739 S Typhi, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/b s atcc 6633 b c atcc 11778 e f atcc 29212 s a atcc 6538 s a atcc 43300 e coli atcc 8739 s typhi/product/ATCC
    Average 99 stars, based on 1 article reviews
    b s atcc 6633 b c atcc 11778 e f atcc 29212 s a atcc 6538 s a atcc 43300 e coli atcc 8739 s typhi - by Bioz Stars, 2026-03
    99/100 stars
    		  Buy from Supplier
    2020 s aureus atcc 6538 s aureus atcc 43300 s epidermidis atcc 35984 l monocytogenes atcc 13932 b subtilis atcc 6633 s aureus 7786 mrsa  (ATCC)
    99
    ATCC 2020 s aureus atcc 6538 s aureus atcc 43300 s epidermidis atcc 35984 l monocytogenes atcc 13932 b subtilis atcc 6633 s aureus 7786 mrsa
    A Evolution of resistant mutants of SMJ-2 (blue) and ciprofloxacin (brown) in cation-adjusted broth on S. aureus ATCC 29213, B S. aureus ATCC 43300, and ( C ) B. subtilis MTCC 121. Cells were passaged every 24 h. D , E Time-kill kinetic assay of SMJ-2 and SMJ-4 on S. aureus ATCC-MRSA-43300 in logarithmic and stationary phase respectively, the concentration of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin at 10 × MIC. MIC of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin were 2, 4, 1, 2, and 64 µg mL −1 respectively; (L.O.D. = Limit of Detection), F Photographic representation of SMJ-2, SMJ-4, vancomycin and linezolid treatment on S. aureus ATCC-MRSA-43300 in logarithmic phase, G Oxacillin treatment to S. aureus ATCC-29213 form persister cells, H Persister killing assay in the presence of SMJ-2 at 5 × MIC, 10 × MIC, and 20 × MIC and linezolid was used as positive control at 10 × MIC, and 20 × MIC. Experiments ( A – C ) represent two individual repeats ( n = 2 biologically independent experiments), D , E , G , and H represent three individual repeats ( n = 3 biologically independent samples), and the results correspond to average ± standard deviation.
    2020 S Aureus Atcc 6538 S Aureus Atcc 43300 S Epidermidis Atcc 35984 L Monocytogenes Atcc 13932 B Subtilis Atcc 6633 S Aureus 7786 Mrsa, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/2020 s aureus atcc 6538 s aureus atcc 43300 s epidermidis atcc 35984 l monocytogenes atcc 13932 b subtilis atcc 6633 s aureus 7786 mrsa/product/ATCC
    Average 99 stars, based on 1 article reviews
    2020 s aureus atcc 6538 s aureus atcc 43300 s epidermidis atcc 35984 l monocytogenes atcc 13932 b subtilis atcc 6633 s aureus 7786 mrsa - by Bioz Stars, 2026-03
    99/100 stars
    		  Buy from Supplier
    s aureus atcc 6538 s aureus atcc 43300 s epidermidis atcc 35984 l monocytogenes atcc 13932 b subtilis atcc 6633 s aureus 7786 mrsa  (ATCC)
    99
    ATCC s aureus atcc 6538 s aureus atcc 43300 s epidermidis atcc 35984 l monocytogenes atcc 13932 b subtilis atcc 6633 s aureus 7786 mrsa
    A Evolution of resistant mutants of SMJ-2 (blue) and ciprofloxacin (brown) in cation-adjusted broth on S. aureus ATCC 29213, B S. aureus ATCC 43300, and ( C ) B. subtilis MTCC 121. Cells were passaged every 24 h. D , E Time-kill kinetic assay of SMJ-2 and SMJ-4 on S. aureus ATCC-MRSA-43300 in logarithmic and stationary phase respectively, the concentration of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin at 10 × MIC. MIC of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin were 2, 4, 1, 2, and 64 µg mL −1 respectively; (L.O.D. = Limit of Detection), F Photographic representation of SMJ-2, SMJ-4, vancomycin and linezolid treatment on S. aureus ATCC-MRSA-43300 in logarithmic phase, G Oxacillin treatment to S. aureus ATCC-29213 form persister cells, H Persister killing assay in the presence of SMJ-2 at 5 × MIC, 10 × MIC, and 20 × MIC and linezolid was used as positive control at 10 × MIC, and 20 × MIC. Experiments ( A – C ) represent two individual repeats ( n = 2 biologically independent experiments), D , E , G , and H represent three individual repeats ( n = 3 biologically independent samples), and the results correspond to average ± standard deviation.
    S Aureus Atcc 6538 S Aureus Atcc 43300 S Epidermidis Atcc 35984 L Monocytogenes Atcc 13932 B Subtilis Atcc 6633 S Aureus 7786 Mrsa, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/s aureus atcc 6538 s aureus atcc 43300 s epidermidis atcc 35984 l monocytogenes atcc 13932 b subtilis atcc 6633 s aureus 7786 mrsa/product/ATCC
    Average 99 stars, based on 1 article reviews
    s aureus atcc 6538 s aureus atcc 43300 s epidermidis atcc 35984 l monocytogenes atcc 13932 b subtilis atcc 6633 s aureus 7786 mrsa - by Bioz Stars, 2026-03
    99/100 stars
    		  Buy from Supplier
    s aureus atcc 29213 s aureus atcc 43300 b subtilis atcc 6633  (ATCC)
    99
    ATCC s aureus atcc 29213 s aureus atcc 43300 b subtilis atcc 6633
    A Evolution of resistant mutants of SMJ-2 (blue) and ciprofloxacin (brown) in cation-adjusted broth on S. aureus ATCC 29213, B S. aureus ATCC 43300, and ( C ) B. subtilis MTCC 121. Cells were passaged every 24 h. D , E Time-kill kinetic assay of SMJ-2 and SMJ-4 on S. aureus ATCC-MRSA-43300 in logarithmic and stationary phase respectively, the concentration of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin at 10 × MIC. MIC of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin were 2, 4, 1, 2, and 64 µg mL −1 respectively; (L.O.D. = Limit of Detection), F Photographic representation of SMJ-2, SMJ-4, vancomycin and linezolid treatment on S. aureus ATCC-MRSA-43300 in logarithmic phase, G Oxacillin treatment to S. aureus ATCC-29213 form persister cells, H Persister killing assay in the presence of SMJ-2 at 5 × MIC, 10 × MIC, and 20 × MIC and linezolid was used as positive control at 10 × MIC, and 20 × MIC. Experiments ( A – C ) represent two individual repeats ( n = 2 biologically independent experiments), D , E , G , and H represent three individual repeats ( n = 3 biologically independent samples), and the results correspond to average ± standard deviation.
    S Aureus Atcc 29213 S Aureus Atcc 43300 B Subtilis Atcc 6633, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/s aureus atcc 29213 s aureus atcc 43300 b subtilis atcc 6633/product/ATCC
    Average 99 stars, based on 1 article reviews
    s aureus atcc 29213 s aureus atcc 43300 b subtilis atcc 6633 - by Bioz Stars, 2026-03
    99/100 stars
    		  Buy from Supplier
    s aureus atcc 43300 b  (ATCC)
    99
    ATCC s aureus atcc 43300 b
    A Evolution of resistant mutants of SMJ-2 (blue) and ciprofloxacin (brown) in cation-adjusted broth on S. aureus ATCC 29213, B S. aureus ATCC 43300, and ( C ) B. subtilis MTCC 121. Cells were passaged every 24 h. D , E Time-kill kinetic assay of SMJ-2 and SMJ-4 on S. aureus ATCC-MRSA-43300 in logarithmic and stationary phase respectively, the concentration of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin at 10 × MIC. MIC of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin were 2, 4, 1, 2, and 64 µg mL −1 respectively; (L.O.D. = Limit of Detection), F Photographic representation of SMJ-2, SMJ-4, vancomycin and linezolid treatment on S. aureus ATCC-MRSA-43300 in logarithmic phase, G Oxacillin treatment to S. aureus ATCC-29213 form persister cells, H Persister killing assay in the presence of SMJ-2 at 5 × MIC, 10 × MIC, and 20 × MIC and linezolid was used as positive control at 10 × MIC, and 20 × MIC. Experiments ( A – C ) represent two individual repeats ( n = 2 biologically independent experiments), D , E , G , and H represent three individual repeats ( n = 3 biologically independent samples), and the results correspond to average ± standard deviation.
    S Aureus Atcc 43300 B, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/s aureus atcc 43300 b/product/ATCC
    Average 99 stars, based on 1 article reviews
    s aureus atcc 43300 b - by Bioz Stars, 2026-03
    99/100 stars
    		  Buy from Supplier
    strains b subtilis 168 dsm 402 s aureus dsm 20231 s aureus atcc 43300 3a n a n a n a  (ATCC)
    99
    ATCC strains b subtilis 168 dsm 402 s aureus dsm 20231 s aureus atcc 43300 3a n a n a n a
    A Evolution of resistant mutants of SMJ-2 (blue) and ciprofloxacin (brown) in cation-adjusted broth on S. aureus ATCC 29213, B S. aureus ATCC 43300, and ( C ) B. subtilis MTCC 121. Cells were passaged every 24 h. D , E Time-kill kinetic assay of SMJ-2 and SMJ-4 on S. aureus ATCC-MRSA-43300 in logarithmic and stationary phase respectively, the concentration of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin at 10 × MIC. MIC of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin were 2, 4, 1, 2, and 64 µg mL −1 respectively; (L.O.D. = Limit of Detection), F Photographic representation of SMJ-2, SMJ-4, vancomycin and linezolid treatment on S. aureus ATCC-MRSA-43300 in logarithmic phase, G Oxacillin treatment to S. aureus ATCC-29213 form persister cells, H Persister killing assay in the presence of SMJ-2 at 5 × MIC, 10 × MIC, and 20 × MIC and linezolid was used as positive control at 10 × MIC, and 20 × MIC. Experiments ( A – C ) represent two individual repeats ( n = 2 biologically independent experiments), D , E , G , and H represent three individual repeats ( n = 3 biologically independent samples), and the results correspond to average ± standard deviation.
    Strains B Subtilis 168 Dsm 402 S Aureus Dsm 20231 S Aureus Atcc 43300 3a N A N A N A, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/strains b subtilis 168 dsm 402 s aureus dsm 20231 s aureus atcc 43300 3a n a n a n a/product/ATCC
    Average 99 stars, based on 1 article reviews
    strains b subtilis 168 dsm 402 s aureus dsm 20231 s aureus atcc 43300 3a n a n a n a - by Bioz Stars, 2026-03
    99/100 stars
    		  Buy from Supplier
    s aureus mrsa atcc 43300 gram 74 b  (ATCC)
    99
    ATCC s aureus mrsa atcc 43300 gram 74 b
    A Evolution of resistant mutants of SMJ-2 (blue) and ciprofloxacin (brown) in cation-adjusted broth on S. aureus ATCC 29213, B S. aureus ATCC 43300, and ( C ) B. subtilis MTCC 121. Cells were passaged every 24 h. D , E Time-kill kinetic assay of SMJ-2 and SMJ-4 on S. aureus ATCC-MRSA-43300 in logarithmic and stationary phase respectively, the concentration of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin at 10 × MIC. MIC of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin were 2, 4, 1, 2, and 64 µg mL −1 respectively; (L.O.D. = Limit of Detection), F Photographic representation of SMJ-2, SMJ-4, vancomycin and linezolid treatment on S. aureus ATCC-MRSA-43300 in logarithmic phase, G Oxacillin treatment to S. aureus ATCC-29213 form persister cells, H Persister killing assay in the presence of SMJ-2 at 5 × MIC, 10 × MIC, and 20 × MIC and linezolid was used as positive control at 10 × MIC, and 20 × MIC. Experiments ( A – C ) represent two individual repeats ( n = 2 biologically independent experiments), D , E , G , and H represent three individual repeats ( n = 3 biologically independent samples), and the results correspond to average ± standard deviation.
    S Aureus Mrsa Atcc 43300 Gram 74 B, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/s aureus mrsa atcc 43300 gram 74 b/product/ATCC
    Average 99 stars, based on 1 article reviews
    s aureus mrsa atcc 43300 gram 74 b - by Bioz Stars, 2026-03
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    A Evolution of resistant mutants of SMJ-2 (blue) and ciprofloxacin (brown) in cation-adjusted broth on S. aureus ATCC 29213, B S. aureus ATCC 43300, and ( C ) B. subtilis MTCC 121. Cells were passaged every 24 h. D , E Time-kill kinetic assay of SMJ-2 and SMJ-4 on S. aureus ATCC-MRSA-43300 in logarithmic and stationary phase respectively, the concentration of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin at 10 × MIC. MIC of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin were 2, 4, 1, 2, and 64 µg mL −1 respectively; (L.O.D. = Limit of Detection), F Photographic representation of SMJ-2, SMJ-4, vancomycin and linezolid treatment on S. aureus ATCC-MRSA-43300 in logarithmic phase, G Oxacillin treatment to S. aureus ATCC-29213 form persister cells, H Persister killing assay in the presence of SMJ-2 at 5 × MIC, 10 × MIC, and 20 × MIC and linezolid was used as positive control at 10 × MIC, and 20 × MIC. Experiments ( A – C ) represent two individual repeats ( n = 2 biologically independent experiments), D , E , G , and H represent three individual repeats ( n = 3 biologically independent samples), and the results correspond to average ± standard deviation.

    Journal: Communications Biology

    Article Title: Synthetic indole derivatives as an antibacterial agent inhibiting respiratory metabolism of multidrug-resistant gram-positive bacteria

    doi: 10.1038/s42003-024-06996-8

    Figure Lengend Snippet: A Evolution of resistant mutants of SMJ-2 (blue) and ciprofloxacin (brown) in cation-adjusted broth on S. aureus ATCC 29213, B S. aureus ATCC 43300, and ( C ) B. subtilis MTCC 121. Cells were passaged every 24 h. D , E Time-kill kinetic assay of SMJ-2 and SMJ-4 on S. aureus ATCC-MRSA-43300 in logarithmic and stationary phase respectively, the concentration of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin at 10 × MIC. MIC of SMJ-2, SMJ-4, vancomycin, linezolid, and oxacillin were 2, 4, 1, 2, and 64 µg mL −1 respectively; (L.O.D. = Limit of Detection), F Photographic representation of SMJ-2, SMJ-4, vancomycin and linezolid treatment on S. aureus ATCC-MRSA-43300 in logarithmic phase, G Oxacillin treatment to S. aureus ATCC-29213 form persister cells, H Persister killing assay in the presence of SMJ-2 at 5 × MIC, 10 × MIC, and 20 × MIC and linezolid was used as positive control at 10 × MIC, and 20 × MIC. Experiments ( A – C ) represent two individual repeats ( n = 2 biologically independent experiments), D , E , G , and H represent three individual repeats ( n = 3 biologically independent samples), and the results correspond to average ± standard deviation.

    Article Snippet: A Evolution of resistant mutants of SMJ-2 (blue) and ciprofloxacin (brown) in cation-adjusted broth on S. aureus ATCC 29213, B S. aureus ATCC 43300, and ( C ) B. subtilis MTCC 121.

    Techniques: Kinetic Assay, Concentration Assay, Positive Control, Standard Deviation